Today's guest is Emma Vitalini, Head of Global Digital Health Technology Innovation at Amgen, where she leads initiatives at the intersection of digital health, data strategy, and clinical innovation. Emma joins Emerj Editorial Senior Editor Marilie Fouche to explore how data and AI are reshaping patient recruitment, consent, and execution in clinical trials, with a focus on decentralized models, scalable compliance, and explainable AI in regulated environments. Emma also shares practical guidance for enterprise leaders on where AI is delivering near-term ROI today, including accelerating patient screening by surfacing unstructured data, reducing enrollment delays through digital and remote monitoring tools, and designing modular, plug-and-play AI platforms that balance speed, flexibility, and regulatory trust. Want to share your AI adoption story with executive peers? Click emerj.com/expert2 for more information and to be a potential future guest on the 'AI in Business' podcast! If you've enjoyed or benefited from some of the insights of this episode, consider leaving us a five-star review on Apple Podcasts, and let us know what you learned, found helpful, or liked most about this show!

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related